
ROSEN urges investors in Skye Bioscience to act before January 2026 deadline
The law firm Rosen Law Firm is sounding the alarm to anyone who purchased securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024...
Found 7,473 articles